These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24038913)
1. Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group. Batra V; Sands SA; Holmes E; Geyer JR; Yates A; Becker L; Burger P; Gilles F; Wisoff J; Allen JC; Pollack IF; Finlay JL Pediatr Blood Cancer; 2014 Jan; 61(1):151-7. PubMed ID: 24038913 [TBL] [Abstract][Full Text] [Related]
2. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945. Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report. Sands SA; Zhou T; O'Neil SH; Patel SK; Allen J; McGuire Cullen P; Kaleita TA; Noll R; Sklar C; Finlay JL J Clin Oncol; 2012 Mar; 30(9):943-9. PubMed ID: 22355055 [TBL] [Abstract][Full Text] [Related]
4. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849 [TBL] [Abstract][Full Text] [Related]
5. Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials. Espinoza JC; Haley K; Patel N; Dhall G; Gardner S; Allen J; Torkildson J; Cornelius A; Rassekh R; Bedros A; Etzl M; Garvin J; Pradhan K; Corbett R; Sullivan M; McGowage G; Stein D; Jasty R; Sands SA; Ji L; Sposto R; Finlay JL Pediatr Blood Cancer; 2016 Oct; 63(10):1806-13. PubMed ID: 27332770 [TBL] [Abstract][Full Text] [Related]
6. The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience. Bouffet E; Allen JC; Boyett JM; Yates A; Gilles F; Burger PC; Davis RL; Becker LE; Pollack IF; Finlay JL J Neurosurg Pediatr; 2016 Apr; 17(4):453-9. PubMed ID: 26684767 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of centrally located low-grade glioma in children. Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612 [TBL] [Abstract][Full Text] [Related]
8. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). Benesch M; Wagner S; Berthold F; Wolff JE J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999 [TBL] [Abstract][Full Text] [Related]
9. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group. Sorrell AD; Alonzo TA; Hilden JM; Gerbing RB; Loew TW; Hathaway L; Barnard D; Taub JW; Ravindranath Y; Smith FO; Arceci RJ; Woods WG; Gamis AS Cancer; 2012 Oct; 118(19):4806-14. PubMed ID: 22392565 [TBL] [Abstract][Full Text] [Related]
10. Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience. Hyder DJ; Sung L; Pollack IF; Gilles FH; Yates AJ; Davis RL; Boyett JM; Finlay JL J Neurooncol; 2007 May; 83(1):1-8. PubMed ID: 17252186 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490 [TBL] [Abstract][Full Text] [Related]
12. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186 [TBL] [Abstract][Full Text] [Related]
15. Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials. Osorio DS; Patel N; Ji L; Sposto R; Stanek J; Gardner SL; Allen JC; Cornelius A; McCowage GB; Termuhlen A; Dunkel IJ; Comito M; Garvin J; Finlay JL J Neurooncol; 2018 Dec; 140(3):717-725. PubMed ID: 30392092 [TBL] [Abstract][Full Text] [Related]
16. Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients. Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Stensvold E; Brandal P J Neurosurg Pediatr; 2013 Sep; 12(3):241-6. PubMed ID: 23870041 [TBL] [Abstract][Full Text] [Related]
17. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Pollack IF; Boyett JM; Yates AJ; Burger PC; Gilles FH; Davis RL; Finlay JL; Neuro Oncol; 2003 Jul; 5(3):197-207. PubMed ID: 12816726 [TBL] [Abstract][Full Text] [Related]
18. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience. Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862 [TBL] [Abstract][Full Text] [Related]
19. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter? Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159 [TBL] [Abstract][Full Text] [Related]
20. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. Shaw EG; Wang M; Coons SW; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP J Clin Oncol; 2012 Sep; 30(25):3065-70. PubMed ID: 22851558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]